Preclinical Single Photon Emission Computed Tomography (SPECT)
Preclinical SPECT imaging uses gamma rays to image rodent models of disease and is often combine ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Structural Imaging 1.2.3 Functional Imaging 1.3 Market by Application 1.3.1 Global Preclinical Positron Emission Tomography (PET) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pharmaceutical Companies 1.3.3 Contract Research Organization (CRO’s) 1.3.4 Biotech Companies 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Preclinical Positron Emission Tomography (PET) Market Perspective (2016-2027) 2.2 Preclinical Positron Emission Tomography (PET) Growth Trends by Regions 2.2.1 Preclinical Positron Emission Tomography (PET) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Preclinical Positron Emission Tomography (PET) Historic Market Share by Regions (2016-2021) 2.2.3 Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Regions (2022-2027) 2.3 Preclinical Positron Emission Tomography (PET) Industry Dynamic 2.3.1 Preclinical Positron Emission Tomography (PET) Market Trends 2.3.2 Preclinical Positron Emission Tomography (PET) Market Drivers 2.3.3 Preclinical Positron Emission Tomography (PET) Market Challenges 2.3.4 Preclinical Positron Emission Tomography (PET) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Preclinical Positron Emission Tomography (PET) Players by Revenue 3.1.1 Global Top Preclinical Positron Emission Tomography (PET) Players by Revenue (2016-2021) 3.1.2 Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Players (2016-2021) 3.2 Global Preclinical Positron Emission Tomography (PET) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Preclinical Positron Emission Tomography (PET) Revenue 3.4 Global Preclinical Positron Emission Tomography (PET) Market Concentration Ratio 3.4.1 Global Preclinical Positron Emission Tomography (PET) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Preclinical Positron Emission Tomography (PET) Revenue in 2020 3.5 Preclinical Positron Emission Tomography (PET) Key Players Head office and Area Served 3.6 Key Players Preclinical Positron Emission Tomography (PET) Product Solution and Service 3.7 Date of Enter into Preclinical Positron Emission Tomography (PET) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Preclinical Positron Emission Tomography (PET) Breakdown Data by Type 4.1 Global Preclinical Positron Emission Tomography (PET) Historic Market Size by Type (2016-2021) 4.2 Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Type (2022-2027) 5 Preclinical Positron Emission Tomography (PET) Breakdown Data by Application 5.1 Global Preclinical Positron Emission Tomography (PET) Historic Market Size by Application (2016-2021) 5.2 Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Preclinical Positron Emission Tomography (PET) Market Size (2016-2027) 6.2 North America Preclinical Positron Emission Tomography (PET) Market Size by Type 6.2.1 North America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) 6.2.2 North America Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) 6.2.3 North America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2027) 6.3 North America Preclinical Positron Emission Tomography (PET) Market Size by Application 6.3.1 North America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) 6.3.2 North America Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) 6.3.3 North America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2027) 6.4 North America Preclinical Positron Emission Tomography (PET) Market Size by Country 6.4.1 North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) 6.4.2 North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Preclinical Positron Emission Tomography (PET) Market Size (2016-2027) 7.2 Europe Preclinical Positron Emission Tomography (PET) Market Size by Type 7.2.1 Europe Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) 7.2.2 Europe Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) 7.2.3 Europe Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2027) 7.3 Europe Preclinical Positron Emission Tomography (PET) Market Size by Application 7.3.1 Europe Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) 7.3.2 Europe Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) 7.3.3 Europe Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2027) 7.4 Europe Preclinical Positron Emission Tomography (PET) Market Size by Country 7.4.1 Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) 7.4.2 Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size (2016-2027) 8.2 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type 8.2.1 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2027) 8.3 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application 8.3.1 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2027) 8.4 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region 8.4.1 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Preclinical Positron Emission Tomography (PET) Market Size (2016-2027) 9.2 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type 9.2.1 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) 9.2.2 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) 9.2.3 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2027) 9.3 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application 9.3.1 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) 9.3.2 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) 9.3.3 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2027) 9.4 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country 9.4.1 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) 9.4.2 Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size (2016-2027) 10.2 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type 10.2.1 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2027) 10.3 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application 10.3.1 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2027) 10.4 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country 10.4.1 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 TriFoil Imaging 11.1.1 TriFoil Imaging Company Details 11.1.2 TriFoil Imaging Business Overview 11.1.3 TriFoil Imaging Preclinical Positron Emission Tomography (PET) Introduction 11.1.4 TriFoil Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) 11.1.5 TriFoil Imaging Recent Development 11.2 Bruker Corporation 11.2.1 Bruker Corporation Company Details 11.2.2 Bruker Corporation Business Overview 11.2.3 Bruker Corporation Preclinical Positron Emission Tomography (PET) Introduction 11.2.4 Bruker Corporation Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) 11.2.5 Bruker Corporation Recent Development 11.3 Mediso 11.3.1 Mediso Company Details 11.3.2 Mediso Business Overview 11.3.3 Mediso Preclinical Positron Emission Tomography (PET) Introduction 11.3.4 Mediso Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) 11.3.5 Mediso Recent Development 11.4 Spectral Instruments Imaging 11.4.1 Spectral Instruments Imaging Company Details 11.4.2 Spectral Instruments Imaging Business Overview 11.4.3 Spectral Instruments Imaging Preclinical Positron Emission Tomography (PET) Introduction 11.4.4 Spectral Instruments Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) 11.4.5 Spectral Instruments Imaging Recent Development 11.5 MR Solutions 11.5.1 MR Solutions Company Details 11.5.2 MR Solutions Business Overview 11.5.3 MR Solutions Preclinical Positron Emission Tomography (PET) Introduction 11.5.4 MR Solutions Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) 11.5.5 MR Solutions Recent Development 11.6 Aspect Imaging 11.6.1 Aspect Imaging Company Details 11.6.2 Aspect Imaging Business Overview 11.6.3 Aspect Imaging Preclinical Positron Emission Tomography (PET) Introduction 11.6.4 Aspect Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) 11.6.5 Aspect Imaging Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Preclinical Positron Emission Tomography (PET) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Structural Imaging Table 3. Key Players of Functional Imaging Table 4. Global Preclinical Positron Emission Tomography (PET) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global Preclinical Positron Emission Tomography (PET) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Preclinical Positron Emission Tomography (PET) Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global Preclinical Positron Emission Tomography (PET) Market Share by Regions (2016-2021) Table 8. Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global Preclinical Positron Emission Tomography (PET) Market Share by Regions (2022-2027) Table 10. Preclinical Positron Emission Tomography (PET) Market Trends Table 11. Preclinical Positron Emission Tomography (PET) Market Drivers Table 12. Preclinical Positron Emission Tomography (PET) Market Challenges Table 13. Preclinical Positron Emission Tomography (PET) Market Restraints Table 14. Global Preclinical Positron Emission Tomography (PET) Revenue by Players (2016-2021) & (US$ Million) Table 15. Global Preclinical Positron Emission Tomography (PET) Market Share by Players (2016-2021) Table 16. Global Top Preclinical Positron Emission Tomography (PET) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical Positron Emission Tomography (PET) as of 2020) Table 17. Ranking of Global Top Preclinical Positron Emission Tomography (PET) Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by Preclinical Positron Emission Tomography (PET) Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Preclinical Positron Emission Tomography (PET) Product Solution and Service Table 21. Date of Enter into Preclinical Positron Emission Tomography (PET) Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million) Table 24. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Type (2016-2021) Table 25. Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global Preclinical Positron Emission Tomography (PET) Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Application (2016-2021) Table 29. Global Preclinical Positron Emission Tomography (PET) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million) Table 32. North America Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) & (US$ Million) Table 33. North America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) (US$ Million) Table 34. North America Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) & (US$ Million) Table 35. North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) & (US$ Million) Table 36. North America Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million) Table 38. Europe Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) (US$ Million) Table 40. Europe Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size by Country (2022-2027) & (US$ Million) Table 61. TriFoil Imaging Company Details Table 62. TriFoil Imaging Business Overview Table 63. TriFoil Imaging Preclinical Positron Emission Tomography (PET) Product Table 64. TriFoil Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million) Table 65. TriFoil Imaging Recent Development Table 66. Bruker Corporation Company Details Table 67. Bruker Corporation Business Overview Table 68. Bruker Corporation Preclinical Positron Emission Tomography (PET) Product Table 69. Bruker Corporation Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million) Table 70. Bruker Corporation Recent Development Table 71. Mediso Company Details Table 72. Mediso Business Overview Table 73. Mediso Preclinical Positron Emission Tomography (PET) Product Table 74. Mediso Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million) Table 75. Mediso Recent Development Table 76. Spectral Instruments Imaging Company Details Table 77. Spectral Instruments Imaging Business Overview Table 78. Spectral Instruments Imaging Preclinical Positron Emission Tomography (PET) Product Table 79. Spectral Instruments Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million) Table 80. Spectral Instruments Imaging Recent Development Table 81. MR Solutions Company Details Table 82. MR Solutions Business Overview Table 83. MR Solutions Preclinical Positron Emission Tomography (PET) Product Table 84. MR Solutions Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million) Table 85. MR Solutions Recent Development Table 86. Aspect Imaging Company Details Table 87. Aspect Imaging Business Overview Table 88. Aspect Imaging Preclinical Positron Emission Tomography (PET) Product Table 89. Aspect Imaging Revenue in Preclinical Positron Emission Tomography (PET) Business (2016-2021) & (US$ Million) Table 90. Aspect Imaging Recent Development Table 91. Research Programs/Design for This Report Table 92. Key Data Information from Secondary Sources Table 93. Key Data Information from Primary Sources List of Figures Figure 1. Global Preclinical Positron Emission Tomography (PET) Market Share by Type: 2020 VS 2027 Figure 2. Structural Imaging Features Figure 3. Functional Imaging Features Figure 4. Global Preclinical Positron Emission Tomography (PET) Market Share by Application: 2020 VS 2027 Figure 5. Pharmaceutical Companies Case Studies Figure 6. Contract Research Organization (CRO’s) Case Studies Figure 7. Biotech Companies Case Studies Figure 8. Others Case Studies Figure 9. Preclinical Positron Emission Tomography (PET) Report Years Considered Figure 10. Global Preclinical Positron Emission Tomography (PET) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Preclinical Positron Emission Tomography (PET) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Preclinical Positron Emission Tomography (PET) Market Share by Regions: 2020 VS 2027 Figure 13. Global Preclinical Positron Emission Tomography (PET) Market Share by Regions (2022-2027) Figure 14. Global Preclinical Positron Emission Tomography (PET) Market Share by Players in 2020 Figure 15. Global Top Preclinical Positron Emission Tomography (PET) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical Positron Emission Tomography (PET) as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Preclinical Positron Emission Tomography (PET) Revenue in 2020 Figure 17. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Type (2016-2021) Figure 18. Global Preclinical Positron Emission Tomography (PET) Revenue Market Share by Type (2022-2027) Figure 19. North America Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Preclinical Positron Emission Tomography (PET) Market Share by Type (2016-2027) Figure 21. North America Preclinical Positron Emission Tomography (PET) Market Share by Application (2016-2027) Figure 22. North America Preclinical Positron Emission Tomography (PET) Market Share by Country (2016-2027) Figure 23. United States Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Preclinical Positron Emission Tomography (PET) Market Share by Type (2016-2027) Figure 27. Europe Preclinical Positron Emission Tomography (PET) Market Share by Application (2016-2027) Figure 28. Europe Preclinical Positron Emission Tomography (PET) Market Share by Country (2016-2027) Figure 29. Germany Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Share by Type (2016-2027) Figure 37. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Share by Application (2016-2027) Figure 38. Asia-Pacific Preclinical Positron Emission Tomography (PET) Market Share by Region (2016-2027) Figure 39. China Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Preclinical Positron Emission Tomography (PET) Market Share by Type (2016-2027) Figure 47. Latin America Preclinical Positron Emission Tomography (PET) Market Share by Application (2016-2027) Figure 48. Latin America Preclinical Positron Emission Tomography (PET) Market Share by Country (2016-2027) Figure 49. Mexico Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Share by Type (2016-2027) Figure 53. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Share by Application (2016-2027) Figure 54. Middle East & Africa Preclinical Positron Emission Tomography (PET) Market Share by Country (2016-2027) Figure 55. Turkey Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Preclinical Positron Emission Tomography (PET) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. TriFoil Imaging Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021) Figure 59. Bruker Corporation Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021) Figure 60. Mediso Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021) Figure 61. Spectral Instruments Imaging Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021) Figure 62. MR Solutions Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021) Figure 63. Aspect Imaging Revenue Growth Rate in Preclinical Positron Emission Tomography (PET) Business (2016-2021) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed
TriFoil Imaging Bruker Corporation Mediso Spectral Instruments Imaging MR Solutions Aspect Imaging
Preclinical SPECT imaging uses gamma rays to image rodent models of disease and is often combine ... Read More
MPI is a tomographic imaging technique that detects the magnetic properties of iron-oxide nanopar ... Read More
An x-ray (radiograph) is a penetrating form of high-energy electromagnetic radiation and noninva ... Read More
Optical Coherence Tomography (OCT) is an imagining technique that incorporates the reflection of ... Read More